Förpackning om 10 vialer6 i lagerSpara 25 %PT-141 10 mg
Bremelanotid melanokortinagonist
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Enbart för forskningsbruk. Denna förening säljs strikt för in vitro-forskning och laboratorieändamål och är inte avsedd för mänsklig konsumtion eller terapeutisk användning. Genom att köpa bekräftar du att du är en kvalificerad forskare och godkänner vår fullständiga ansvarsfriskrivning.
Endast 6 förpackningar kvar
Syntetisk melanokortinreceptoragonist studerad för effekter på neurala vägar kopplade till sexuell respons i forskningsapplikationer.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanism
Forskning tyder på primär agonism av MC4R med effekter i centrala nervsystemet på neurokemiska markörer hos studiedeltagare.
HPLC-verifierad mot en renhetsspecifikation på ≥99 %. Oberoende testad av ackrediterade tredjepartslaboratorier.
PT-141 — vanliga frågor
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Guider relaterade till PT-141
Forskare utforskar också
UtvaldFörpackning om 10 vialerSpara 17 %HGH
Lyofiliserat pulver10 IU · 4 strengths
Rekombinant humant tillväxthormon
I 2 stackar
Förpackning om 10 vialerSpara 18 %Tesamorelin
Lyofiliserat pulver10 mg · 3 strengths
Stabiliserad GHRH-analog
I 1 stack
UtvaldFörpackning om 10 vialerSpara 22 %CJC-1295 + Ipamorelin
Lyofiliserat pulver5 mg + 5 mg
Klassisk GHRH + ghrelinmimetisk stack
I 2 stackar